MLYS
Mineralys Therapeutics, Inc.$27.21-0.03 (-0.11%)Prev Close$27.28·MCap$1.88B·P/E—·Vol340.3K·Yield—
▲
Buys (12M)
3
$53.76M
▼
Sells (12M)
40
$85.11M
◆
Net Activity
Net Seller
$31.35M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Mineralys Therapeutics, Inc. (MLYS) has been mixed between buying and selling, with 3 insider purchases totaling $53.76M and 40 insider sales totaling $85.11M. The most recent insider transaction was by Rodman David Malcom (officer: Chief Medical Officer), who sold $65.8K worth of shares on Jul 10, 2026. Mineralys Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.88B.
MLYS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $30.30 | $65.8K | 57,733 |
| Jun 30, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 75,000 | $26.14 | $1.96M | 631,321 |
| Jun 30, 2026 | Warren Eric | officer: Chief Commercial Officer | Sell | 104,124 | $25.90 | $2.70M | 38,400-73% |
| Jun 17, 2026 | Karydas Daphne | director | Sell | 3,000 | $25.00 | $75.0K | 6,200-33% |
| Jun 17, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 14,474 | $24.19 | $350.1K | 57,095 |
| Jun 12, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 8,519 | $24.20 | $206.2K | 63,443 |
| May 19, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 417 | $27.55 | $11.5K | 63,443 |
| May 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 22,575 | $28.91 | $652.6K | 69,792 |
| Apr 21, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 416 | $31.33 | $13.0K | 69,792 |
| Apr 15, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 20,406 | $26.89 | $548.7K | 76,140 |
| Apr 15, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 15,730 | $26.83 | $422.0K | 689,321 |
| Apr 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,170 | $27.38 | $59.4K | 76,140 |
| Apr 2, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 75,000 | $26.27 | $1.97M | 760,687 |
| Apr 2, 2026 | Karydas Daphne | director | Sell | 3,000 | $25.00 | $75.0K | 6,200-33% |
| Mar 31, 2026 | RA CAPITAL MANAGEMENT, L.P. | director | Buy | 369,000 | $23.75 | $8.76M0.6% OS | 5,825,521 |
| Mar 17, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 417 | $25.65 | $10.7K | 76,140 |
| Mar 16, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 20,406 | $26.61 | $543.0K | 82,489 |
| Mar 10, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $26.84 | $58.3K | 82,489 |
| Feb 17, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | 417 | $27.59 | $11.5K | 0 |
| Feb 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 16,863 | $28.05 | $473.0K | 50,958 |
| Feb 11, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $30.21 | $65.6K | 50,437 |
| Jan 20, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 416 | $32.10 | $13.4K | 50,437 |
| Jan 15, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 19,076 | $32.66 | $623.1K | 61,804 |
| Jan 13, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 16,236 | $32.62 | $529.6K | 646,268 |
| Jan 13, 2026 | Levy Adam Scott | officer: CFO and Secretary | Sell | 10,758 | $32.14 | $345.7K | 8,638-55% |
| Jan 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 8,518 | $32.56 | $277.3K | 61,804 |
| Jan 6, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 262,752 | $35.25 | $9.26M | 115,274-70% |
| Nov 21, 2025 | Slingsby Brian Taylor | Director | Sell | 1,000,000 | $43.35 | $43.35M1.5% OS | 7,903,838 |
| Nov 13, 2025 | Congleton Jon | Chief Executive Officer | Sell | 200,000 | $45.44 | $9.09M | 818,499 |
| Nov 13, 2025 | Gold Alexander M | Director | Sell | 34,675 | $45.45 | $1.58M | 5,000-87% |
| Nov 13, 2025 | Karydas Daphne | Director | Sell | 15,000 | $45.99 | $689.8K | 4,885-75% |
| Nov 13, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 119,524 | $44.88 | $5.36M | 137,905-46% |
| Oct 15, 2025 | Congleton Jon | Chief Executive Officer | Sell | 15,100 | $42.67 | $644.3K | 832,857 |
| Oct 15, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 10,758 | $42.01 | $452.0K | 120,257 |
| Oct 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 10,369 | $43.01 | $446.0K | 71,155 |
| Sep 16, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,367 | $36.00 | $409.3K | 83,589 |
| Sep 8, 2025 | AKKARAJU SRINIVAS | Buy | 588,235 | $25.50 | $15.00M0.9% OS | 588,235 | |
| Sep 8, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,176,470 | $25.50 | $30.00M1.8% OS | 5,456,521+27% | |
| Aug 14, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,365 | $12.93 | $147.0K | 92,891 |
| Jul 30, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 73,678 | $14.62 | $1.08M | 193,666-28% |
| Jul 15, 2025 | Congleton Jon | Chief Executive Officer | Sell | 15,884 | $14.51 | $230.4K | 846,405 |
| Jul 15, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 10,758 | $14.45 | $155.5K | 206,612 |
| Jul 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $14.59 | $165.9K | 97,907 |
| Jun 16, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $14.60 | $165.9K | 101,651 |
| May 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $15.29 | $173.8K | 106,669 |
| Apr 25, 2025 | Slingsby Brian Taylor | Director | Buy | 259,259 | $13.50 | $3.50M | 8,903,838 |
| Apr 15, 2025 | Congleton Jon | Chief Executive Officer | Sell | 15,319 | $12.19 | $186.8K | 862,289 |
| Apr 15, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 10,757 | $12.06 | $129.7K | 215,340 |
| Apr 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $14.53 | $165.2K | 120,086 |
| Apr 3, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 55,771 | $15.76 | $879.0K | 141,901-28% |
Showing 1–50 of 77
1 / 2
MLYS Insider Buying Activity
The following table shows recent insider purchases of Mineralys Therapeutics, Inc. (MLYS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | RA CAPITAL MANAGEMENT, L.P. | director | Buy | 369,000 | $23.75 | $8.76M0.6% OS | 5,825,521 |
| Sep 8, 2025 | AKKARAJU SRINIVAS | Buy | 588,235 | $25.50 | $15.00M0.9% OS | 588,235 | |
| Sep 8, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,176,470 | $25.50 | $30.00M1.8% OS | 5,456,521+27% | |
| Apr 25, 2025 | Slingsby Brian Taylor | Director | Buy | 259,259 | $13.50 | $3.50M | 8,903,838 |
MLYS Insider Selling Activity
The following table shows recent insider sales of Mineralys Therapeutics, Inc. (MLYS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $30.30 | $65.8K | 57,733 |
| Jun 30, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 75,000 | $26.14 | $1.96M | 631,321 |
| Jun 30, 2026 | Warren Eric | officer: Chief Commercial Officer | Sell | 104,124 | $25.90 | $2.70M | 38,400-73% |
| Jun 17, 2026 | Karydas Daphne | director | Sell | 3,000 | $25.00 | $75.0K | 6,200-33% |
| Jun 17, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 14,474 | $24.19 | $350.1K | 57,095 |
| Jun 12, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 8,519 | $24.20 | $206.2K | 63,443 |
| May 19, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 417 | $27.55 | $11.5K | 63,443 |
| May 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 22,575 | $28.91 | $652.6K | 69,792 |
| Apr 21, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 416 | $31.33 | $13.0K | 69,792 |
| Apr 15, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 20,406 | $26.89 | $548.7K | 76,140 |
| Apr 15, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 15,730 | $26.83 | $422.0K | 689,321 |
| Apr 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,170 | $27.38 | $59.4K | 76,140 |
| Apr 2, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 75,000 | $26.27 | $1.97M | 760,687 |
| Apr 2, 2026 | Karydas Daphne | director | Sell | 3,000 | $25.00 | $75.0K | 6,200-33% |
| Mar 17, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 417 | $25.65 | $10.7K | 76,140 |
| Mar 16, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 20,406 | $26.61 | $543.0K | 82,489 |
| Mar 10, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $26.84 | $58.3K | 82,489 |
| Feb 17, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | 417 | $27.59 | $11.5K | 0 |
| Feb 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 16,863 | $28.05 | $473.0K | 50,958 |
| Feb 11, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $30.21 | $65.6K | 50,437 |
| Jan 20, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 416 | $32.10 | $13.4K | 50,437 |
| Jan 15, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 19,076 | $32.66 | $623.1K | 61,804 |
| Jan 13, 2026 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 16,236 | $32.62 | $529.6K | 646,268 |
| Jan 13, 2026 | Levy Adam Scott | officer: CFO and Secretary | Sell | 10,758 | $32.14 | $345.7K | 8,638-55% |
| Jan 13, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 8,518 | $32.56 | $277.3K | 61,804 |
| Jan 6, 2026 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 262,752 | $35.25 | $9.26M | 115,274-70% |
| Nov 21, 2025 | Slingsby Brian Taylor | Director | Sell | 1,000,000 | $43.35 | $43.35M1.5% OS | 7,903,838 |
| Nov 13, 2025 | Congleton Jon | Chief Executive Officer | Sell | 200,000 | $45.44 | $9.09M | 818,499 |
| Nov 13, 2025 | Gold Alexander M | Director | Sell | 34,675 | $45.45 | $1.58M | 5,000-87% |
| Nov 13, 2025 | Karydas Daphne | Director | Sell | 15,000 | $45.99 | $689.8K | 4,885-75% |
| Nov 13, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 119,524 | $44.88 | $5.36M | 137,905-46% |
| Oct 15, 2025 | Congleton Jon | Chief Executive Officer | Sell | 15,100 | $42.67 | $644.3K | 832,857 |
| Oct 15, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 10,758 | $42.01 | $452.0K | 120,257 |
| Oct 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 10,369 | $43.01 | $446.0K | 71,155 |
| Sep 16, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,367 | $36.00 | $409.3K | 83,589 |
| Aug 14, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,365 | $12.93 | $147.0K | 92,891 |
| Jul 30, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 73,678 | $14.62 | $1.08M | 193,666-28% |
| Jul 15, 2025 | Congleton Jon | Chief Executive Officer | Sell | 15,884 | $14.51 | $230.4K | 846,405 |
| Jul 15, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 10,758 | $14.45 | $155.5K | 206,612 |
| Jul 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $14.59 | $165.9K | 97,907 |
| Jun 16, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $14.60 | $165.9K | 101,651 |
| May 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $15.29 | $173.8K | 106,669 |
| Apr 15, 2025 | Congleton Jon | Chief Executive Officer | Sell | 15,319 | $12.19 | $186.8K | 862,289 |
| Apr 15, 2025 | Levy Adam Scott | CFO and Secretary | Sell | 10,757 | $12.06 | $129.7K | 215,340 |
| Apr 15, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 11,366 | $14.53 | $165.2K | 120,086 |
| Apr 3, 2025 | Rodman David Malcom | Chief Medical Officer | Sell | 55,771 | $15.76 | $879.0K | 141,901-28% |
MLYS Insiders
Congleton Jon
director, officer: Chief Executive Officer
Bought $105.5KSold $17.13M
17 tradesLast: Jun 30, 2026
Similar Stocks to MLYS
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B